Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference23 articles.
1. Coons, S. J., Kothari, S., Monz, B., & Burke, L. (2011). The patient-reported outcome (PRO) consortium: Filling measurement gaps for PRO endpoints to support labeling claims. Clinical Pharmacology and Therapeutics, 90(5), 743–748.
2. Hayes, R. P., Blum, S. I., Gordon, M. F., Piault, E., Burke, L. B., Slagle, A. F., & Coons, S. J. (2015). The patient-reported outcome (PRO) consortium: Lessons learned along the path to PRO instrument qualification. Therapeutic Innovation and Regulatory Science, 49(1), 132–138.
3. U.S. Food and Drug Administration Center for Drug Evaluation and Research (2014) Guidance for Industry and FDA Staff: Qualification Process for Drug Development Tools.
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm230597.pdf
. Accessed 1 June 2017.
4. Eremenco, S., Cella, D., & Arnold, B. J. (2005). A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof, 28, 212–232.
5. Acquadro, C., Conway, K., Hareendran, A., Aaronson, N., & European Regulatory Issues and Quality of Life Assessment (ERIQA) Group. (2008). Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health, 11(3), 509–5121.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献